| Literature DB >> 30834151 |
T N Sudharshana1, H N Venkatesh1, Borah Nayana1, K Manjunath1, D C Mohana1.
Abstract
The present study investigated the anti-microbial and anti-mycotoxigenic activities of the ethyl acetate extract (EA) and a bioactive compound obtained from an endophytic fungus Alternaria alternata isolated from Catharanthus roseus leaves. A. alternata was identified using PCR-based 5.8S rDNA sequencing. The EA and bioactive compound, p-Coumaric acid (PC), showed concentration-dependent broad-spectrum anti-microbial activity against the tested bacteria, yeast, and fungi with MICs ranging from 7.8 to 250 µg/mL. The in vitro production of aflatoxin B1 (AFB1) from Aspergillus flavus and fumonisin B1 (FB1) from Fusarium verticillioides was completely inhibited by EA and PC at 400 µg/mL. The synthesis of the membrane-bound ergosterol from A. flavus and F. verticillioides was strongly inhibited by PC at 200 µg/mL. The EA and PC were found to show significant anti-microbial and anti-mycotoxigenic activities, hence, they could be explored as protective agents for preventing microbial deterioration and mycotoxins accumulation in food and feedstuffs during pre- and post-harvest and storage.Entities:
Keywords: Endophytic Alternaria alternata; aflatoxin B1; anti-microbial activity; ethyl acetate extract; fumonisin B1; p-Coumaric acid
Year: 2018 PMID: 30834151 PMCID: PMC6394321 DOI: 10.1080/21501203.2018.1541933
Source DB: PubMed Journal: Mycology ISSN: 2150-1203
Figure 1.ESI-MS spectra (a), FT-IR spectra (b) and chemical structure of the p-Coumaric acid.
Anti-bacterial and anti-yeast activities of EA, PC, erythromycin and itraconazole against some food-borne human pathogenic bacteria and yeast.
| EA | PC | Erythromycin/Itraconazole | |||
|---|---|---|---|---|---|
| Microbial isolates | ZOI | MIC | ZOI | MIC | ZOI |
| 13.5 ± 0.6 | 125 | 16.8 ± 1.0 | 62.5 | 10.1 ± 0.3 | |
| 17.2 ± 1.2 | 31.2 | 21.6 ± 1.3 | 15.6 | 15.5 ± 0.7 | |
| 16.8 ± 0.8 | 62.5 | 19.6 ± 0.9 | 15.6 | 8.5 ± 0.4 | |
| 12.9 ± 0.6 | 125 | 16.5 ± 0.7 | 62.5 | 11.8 ± 0.6 | |
| 17.9 ± 0.9 | 31.2 | 20.5 ± 0.8 | 31.2 | 19.5 ± 0.6 | |
| 18.5 ± 1.2 | 31.2 | 21.4 ± 0.9 | 15.6 | 17.2 ± 0.5 | |
| 21.5 ± 1.4 | 15.6 | 24.5 ± 1.3 | 07.8 | 19.6 ± 0.7 | |
| 16.6 ± 0.8 | 125 | 21.6 ± 1.1 | 31.2 | 13.5 ± 0.6 | |
| 20.7 ± 1.0 | 62.5 | 23.3 ± 1.0 | 07.8 | 14.8 ± 0.4 | |
The data given are the means of four replicates ± standard error (p ≤ 0.05). The ZOIs values of EA (150 µg/disc) and PC (100 µg/disc) expressed in mm, and MICs values in µg/mL. Erythromycin (15 mcg/disc) served as positive control for bacteria and Itraconazole (10 mcg/disc) for yeast.
Anti-fungal activity of EA, PC, and indofil Z-78 against different field and storage fungi.
| EA | PC | Indofil Z-78 | |||
|---|---|---|---|---|---|
| Fungal species | %MI | MIC | %MI | MIC | %MI |
| 57.4 ± 2.8 | 31.2 | 73.4 ± 1.4 | 15.6 | 70.6 ± 0.8 | |
| 51.5 ± 2.2 | 62.5 | 70.6 ± 1.9 | 31.2 | 67.4 ± 0.6 | |
| 28.9 ± 1.4 | 250 | 58.4 ± 1.0 | 125 | 51.5 ± 1.1 | |
| 48.5 ± 2.1 | 125 | 65.6 ± 0.9 | 62.5 | 61.2 ± 0.9 | |
| 50.6 ± 0.6 | 62.5 | 69.8 ± 0.8 | 31.2 | 58.6 ± 0.5 | |
| 28.5 ± 0.3 | 250 | 56.6 ± 0.6 | 125 | 52.6 ± 0.8 | |
| 49.5 ± 1.0 | 125 | 66.8 ± 0.8 | 62.5 | 64.6 ± 1.2 | |
| 63.2 ± 2.3 | 31.2 | 80.4 ± 1.7 | 15.6 | 79.8 ± 1.0 | |
| 58.1 ± 1.5 | 31.2 | 82.2 ± 1.2 | 15.6 | 80.2 ± 1. | |
| 51.8 ± 1.2 | 62.5 | 73.5 ± 0.7 | 31.2 | 68.4 ± 0.7 | |
| 41.8 ± 1.0 | 125 | 75.8 ± 1.5 | 62.5 | 70.3 ± 0.7 | |
| 68.5 ± 1.3 | 15.6 | 82.6 ± 1.2 | 07.8 | 82.4 ± 1.5 | |
| 59.8 ± 0.9 | 62.5 | 71.6 ± 1.0 | 31.2 | 65.6 ± 0.9 | |
| 28.5 ± 0.6 | 125 | 59.8 ± 0.8 | 125 | 56.8 ± 0.5 | |
| 23.6 ± 0.8 | 250 | 54.6 ± 1.3 | 125 | 51.4 ± 0.7 | |
The data given are the means of three replicates ± standard error (p ≤ 0.05). The %MIs values of EA (150 µg/mL) and PC (100 µg/mL) are expressed in percentage, and MICs values are expressed in µg/mL. Indofil Z-78 (2 mg/mL) served as a positive control. †Aflatoxin B1 producing strain and ‡Fumonisin B1 producing strain.
Efficacy of EA and PC on AFB1 production from A. flavus and FB1 production F. verticillioides.
| AFB1 production from | FB1 production from | |||||||
|---|---|---|---|---|---|---|---|---|
| Extract concentrations (EA/PC) | EA | PC | EA | PC | EA | PC | EA | PC |
| Control | 1455.6 ± 8.9 | 1455.6 ± 8.9 | 1586.8 ± 9.7 | 1586.8 ± 9.7 | 82.9 ± 3.8 | 82.9 ± 3.8 | 50.5 ± 3.7 | 50.5 ± 3.7 |
| 50 | 1005.2 ± 7.6 | 768.4 ± 7.6 | 1285.6 ± 8.8 | 1145 ± 4.7 | 41.6 ± 2.5 | 22.7 ± 1.8 | 41.6 ± 2.5 | 33.7 ± 2.1 |
| 100 | 614.6 ± 3.9 | 143 ± 1.8 | 895.5 ± 4.5 | 685 ± 4.5 | 10.8 ± 0.7 | 0.0 ± 0.0 | 25.4 ± 2.2 | 14.4 ± 0.8 |
| 200 | 135.8 ± 2.6 | 0.0 ± 0.0 | 564.4 ± 2.7 | 145 ± 2.7 | 0.0 ± 0.0 | 0.0 ± 0.0 | 12.9 ± 1.7 | 0.0 ± 0.0 |
| 400 | 0.0 ± 0.0 | 0.0 ± 0.0 | 195.7 ± 1.6 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
The data given are the means of three replicates ± standard error (p ≤ 0.05). The values of AFB1 production are expressed in µg/mL under in vitro and µg/g under in vivo. The values of FB1 production are expressed in mg/mL under in vitro and mg/g under in vivo.
Figure 2.Inhibitory effect of p-Coumaric acid on the synthesis of ergosterol from A. flavus (a) and F. verticillioides (b).